Previous studies have shown that the pro-oncogenic activity of NR4A1 in cancer cells also involves the regulation of some Sp1-mediated expression of antiapoptotic genes, such as survivin and bcl-2, and maintenance of appropriate intracellular levels of reactive oxygen species (ROS) [6,9]. This evidence concerns the gene BIRC5 and cancer.